The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
about
An Overview of Genetic Changes and Risk of Pancreatic Ductal AdenocarcinomaNanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.Emerging antibodies for the treatment of pancreatic cancer."Heat shock protein 70 in pancreatic diseases: Friend or foe".Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.Biophysical interactions between pancreatic cancer cells and pristine carbon nanotube substrates: Potential application for pancreatic cancer tissue engineering.The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP.Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.How does the tumor microenvironment play a role in hepatobiliary tumors?Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer
P2860
Q28076342-CD9459C1-46F9-4BE5-9EC3-45E94BECDB43Q39129504-883886B1-6598-434C-B889-1A0324766C6AQ39158427-E46BD5EC-03F4-4905-A2BC-5AA3649CF401Q39329712-DF5DEC93-2CCC-419A-A102-8CCB0A6CC249Q41153247-46977753-262A-4457-A56A-06EA24D16D98Q41991343-12DE03B1-C088-447E-B70B-4366B0CBCAB2Q42371622-EFB02EF1-4C91-46C4-AA91-54F88C2046B7Q45559181-5D95B8B2-544E-4CE0-8FC3-A0BEB7FF9518Q47200021-5D4C60FC-6505-4611-937C-515AB999963BQ48820342-54FB23D5-C89E-4B11-9864-F2355713F547Q52725074-C0863257-3F05-41FF-AA27-3FBEDA8C3314Q53700817-6D05A7D7-FAF7-4AC6-A281-2BF014B58B04Q54980764-00A63ECA-2393-4B3B-ACF5-272494ED19D4Q57494120-A1AF9604-71D3-4F61-A48B-0E88E6A08119
P2860
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@ast
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@en
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@nl
type
label
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@ast
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@en
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@nl
prefLabel
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@ast
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@en
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@nl
P2093
P2860
P921
P3181
P356
P1476
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
@en
P2093
Fernando F Blanco
Jonathan R Brody
Jordan M Winter
Kevin O'Hayer
Saswati Chand
P2860
P304
P3181
P356
10.7150/IJBS.14951
P407
P577
2016-01-27T00:00:00Z